Literature DB >> 22969691

Therapeutic Hemapheresis.

Behrouz Mansouri Taleghani1, Erwin Strasser.   

Abstract

Year:  2012        PMID： 22969691      PMCID： PMC3434325          DOI： 10.1159/000341819

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN： 1660-3796            Impact factor:   3.747


× No keyword cloud information.
  6 in total

1.  Guidelines on the use of therapeutic apheresis in clinical practice--evidence-based approach from the Apheresis Applications Committee of the American Society for Apheresis.

Authors:  Zbigniew M Szczepiorkowski; Jeffrey L Winters; Nicholas Bandarenko; Haewon C Kim; Michael L Linenberger; Marisa B Marques; Ravindra Sarode; Joseph Schwartz; Robert Weinstein; Beth H Shaz
Journal:  J Clin Apher       Date:  2010       Impact factor: 2.821

2.  Clinical Results of Extracorporeal Photopheresis.

Authors:  Nina Worel; Gerda Leitner
Journal:  Transfus Med Hemother       Date:  2012-07-26       Impact factor: 3.747

3.  Selective Granulocyte and Monocyte Apheresis as a Non-Pharmacological Option for Patients with Inflammatory Bowel Disease.

Authors:  Gerda C Leitner; Nina Worel; Harald Vogelsang
Journal:  Transfus Med Hemother       Date:  2012-07-31       Impact factor: 3.747

4.  Plasma Exchange and Immunoadsorption of Patients with Thoracic Organ Transplantation.

Authors:  Silke Rummler; Dagmar Barz
Journal:  Transfus Med Hemother       Date:  2012-07-20       Impact factor: 3.747

5.  Leukocyte Depletion by Therapeutic Leukocytapheresis in Patients with Leukemia.

Authors:  Kristina Hölig; Rainer Moog
Journal:  Transfus Med Hemother       Date:  2012-07-26       Impact factor: 3.747

6.  Extracorporeal Treatment for the Acute und Long-Term Outcome of Patients with Life-Threatening Acquired Hemophilia.

Authors:  Heike Zeitler; Gudrun Ulrich-Merzenich; Darius Panek; Georg Goldmann; Natascha Vidovic; Hans-Hermann Brackmann; Johannes Oldenburg
Journal:  Transfus Med Hemother       Date:  2012-07-26       Impact factor: 3.747
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.